STOCK TITAN

[8-K] Bain Capital Specialty Finance, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Sunrun Inc. (RUN) has filed a Form 144 indicating a proposed sale of restricted securities.

  • Securities to be sold: 988 common shares
  • Aggregate market value: $10,670
  • Approximate sale date: 07/07/2025
  • Broker: Charles Schwab & Co., Inc.
  • Exchange: NASDAQ
  • Total shares outstanding: 228,486,470
  • Recent prior sales by same seller: 2,729 shares on 04/07/2025 for gross proceeds of $18,379

The planned sale represents roughly 0.0004% of Sunrun’s outstanding shares, suggesting minimal dilution or market impact. The shares were acquired via an RSU lapse (equity compensation) on 07/07/2025. Form 144 also affirms that the filer possesses no undisclosed material adverse information about Sunrun.

Sunrun Inc. (RUN) ha presentato un modulo Form 144 indicando una proposta di vendita di titoli vincolati.

  • Titoli da vendere: 988 azioni ordinarie
  • Valore di mercato complessivo: 10.670 $
  • Data approssimativa di vendita: 07/07/2025
  • Broker: Charles Schwab & Co., Inc.
  • Borsa: NASDAQ
  • Azioni totali in circolazione: 228.486.470
  • Vendite recenti precedenti dallo stesso venditore: 2.729 azioni il 07/04/2025 per un ricavo lordo di 18.379 $

La vendita pianificata rappresenta circa lo 0,0004% delle azioni in circolazione di Sunrun, indicando un impatto minimo sulla diluizione o sul mercato. Le azioni sono state acquisite tramite la scadenza di RSU (compenso azionario) il 07/07/2025. Il modulo Form 144 conferma inoltre che il dichiarante non possiede informazioni materiali sfavorevoli non divulgate su Sunrun.

Sunrun Inc. (RUN) ha presentado un Formulario 144 indicando una propuesta de venta de valores restringidos.

  • Valores a vender: 988 acciones ordinarias
  • Valor de mercado agregado: 10,670 $
  • Fecha aproximada de venta: 07/07/2025
  • Corredor: Charles Schwab & Co., Inc.
  • Bolsa: NASDAQ
  • Total de acciones en circulación: 228,486,470
  • Ventas recientes previas por el mismo vendedor: 2,729 acciones el 07/04/2025 por ingresos brutos de 18,379 $

La venta planificada representa aproximadamente el 0.0004% de las acciones en circulación de Sunrun, lo que sugiere un impacto o dilución mínima en el mercado. Las acciones fueron adquiridas mediante la liberación de RSU (compensación en acciones) el 07/07/2025. El Formulario 144 también afirma que el declarante no posee información material adversa no divulgada sobre Sunrun.

Sunrun Inc.(RUN)가 Form 144 서류를 제출했습니다 제한된 증권 매각 예정임을 나타냅니다.

  • 매도할 증권: 보통주 988주
  • 총 시가 가치: 10,670달러
  • 예상 매도일: 2025년 7월 7일
  • 중개인: Charles Schwab & Co., Inc.
  • 거래소: NASDAQ
  • 총 발행 주식 수: 228,486,470주
  • 동일 판매자의 최근 이전 매도: 2025년 4월 7일 2,729주, 총 매출 18,379달러

계획된 매도는 Sunrun의 발행 주식의 약 0.0004%에 해당하며, 이는 희석이나 시장 영향이 미미함을 시사합니다. 이 주식들은 2025년 7월 7일 RSU(주식 보상)의 만료를 통해 취득되었습니다. Form 144는 또한 제출자가 Sunrun에 관한 미공개 중요 불리 정보가 없음을 확인합니다.

Sunrun Inc. (RUN) a déposé un formulaire 144 indiquant une vente proposée de titres restreints.

  • Titres à vendre : 988 actions ordinaires
  • Valeur marchande globale : 10 670 $
  • Date approximative de vente : 07/07/2025
  • Intermédiaire : Charles Schwab & Co., Inc.
  • Bourse : NASDAQ
  • Total des actions en circulation : 228 486 470
  • Ventes récentes précédentes par le même vendeur : 2 729 actions le 07/04/2025 pour un produit brut de 18 379 $

La vente prévue représente environ 0,0004 % des actions en circulation de Sunrun, ce qui suggère un impact minimal sur la dilution ou le marché. Les actions ont été acquises via une levée de RSU (compensation en actions) le 07/07/2025. Le formulaire 144 confirme également que le déposant ne détient aucune information défavorable importante non divulguée concernant Sunrun.

Sunrun Inc. (RUN) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von beschränkten Wertpapieren anzeigt.

  • Zu verkaufende Wertpapiere: 988 Stammaktien
  • Gesamtmarktwert: 10.670 $
  • Ungefähres Verkaufsdatum: 07.07.2025
  • Broker: Charles Schwab & Co., Inc.
  • Börse: NASDAQ
  • Gesamtzahl der ausstehenden Aktien: 228.486.470
  • Jüngste frühere Verkäufe desselben Verkäufers: 2.729 Aktien am 07.04.2025 mit Bruttoerlös von 18.379 $

Der geplante Verkauf entspricht etwa 0,0004 % der ausstehenden Sunrun-Aktien und deutet auf minimale Verwässerung oder Markteinfluss hin. Die Aktien wurden am 07.07.2025 durch das Ablaufen von RSUs (Aktienvergütung) erworben. Das Formular 144 bestätigt außerdem, dass der Einreicher keine nicht offengelegten wesentlichen nachteiligen Informationen über Sunrun besitzt.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Tiny Form 144 sale (988 shares) is immaterial to RUN; neutral impact.

The filing discloses a proposed sale worth only $10.7k versus Sunrun’s 228.5 million shares outstanding. Even coupled with the earlier 2,729-share sale, the volumes are immaterial and unlikely to affect liquidity, float, or sentiment. No relationship to the issuer (e.g., insider status) is specified, reducing interpretative weight. Overall, the notice is routine administrative disclosure with negligible investment significance.

Sunrun Inc. (RUN) ha presentato un modulo Form 144 indicando una proposta di vendita di titoli vincolati.

  • Titoli da vendere: 988 azioni ordinarie
  • Valore di mercato complessivo: 10.670 $
  • Data approssimativa di vendita: 07/07/2025
  • Broker: Charles Schwab & Co., Inc.
  • Borsa: NASDAQ
  • Azioni totali in circolazione: 228.486.470
  • Vendite recenti precedenti dallo stesso venditore: 2.729 azioni il 07/04/2025 per un ricavo lordo di 18.379 $

La vendita pianificata rappresenta circa lo 0,0004% delle azioni in circolazione di Sunrun, indicando un impatto minimo sulla diluizione o sul mercato. Le azioni sono state acquisite tramite la scadenza di RSU (compenso azionario) il 07/07/2025. Il modulo Form 144 conferma inoltre che il dichiarante non possiede informazioni materiali sfavorevoli non divulgate su Sunrun.

Sunrun Inc. (RUN) ha presentado un Formulario 144 indicando una propuesta de venta de valores restringidos.

  • Valores a vender: 988 acciones ordinarias
  • Valor de mercado agregado: 10,670 $
  • Fecha aproximada de venta: 07/07/2025
  • Corredor: Charles Schwab & Co., Inc.
  • Bolsa: NASDAQ
  • Total de acciones en circulación: 228,486,470
  • Ventas recientes previas por el mismo vendedor: 2,729 acciones el 07/04/2025 por ingresos brutos de 18,379 $

La venta planificada representa aproximadamente el 0.0004% de las acciones en circulación de Sunrun, lo que sugiere un impacto o dilución mínima en el mercado. Las acciones fueron adquiridas mediante la liberación de RSU (compensación en acciones) el 07/07/2025. El Formulario 144 también afirma que el declarante no posee información material adversa no divulgada sobre Sunrun.

Sunrun Inc.(RUN)가 Form 144 서류를 제출했습니다 제한된 증권 매각 예정임을 나타냅니다.

  • 매도할 증권: 보통주 988주
  • 총 시가 가치: 10,670달러
  • 예상 매도일: 2025년 7월 7일
  • 중개인: Charles Schwab & Co., Inc.
  • 거래소: NASDAQ
  • 총 발행 주식 수: 228,486,470주
  • 동일 판매자의 최근 이전 매도: 2025년 4월 7일 2,729주, 총 매출 18,379달러

계획된 매도는 Sunrun의 발행 주식의 약 0.0004%에 해당하며, 이는 희석이나 시장 영향이 미미함을 시사합니다. 이 주식들은 2025년 7월 7일 RSU(주식 보상)의 만료를 통해 취득되었습니다. Form 144는 또한 제출자가 Sunrun에 관한 미공개 중요 불리 정보가 없음을 확인합니다.

Sunrun Inc. (RUN) a déposé un formulaire 144 indiquant une vente proposée de titres restreints.

  • Titres à vendre : 988 actions ordinaires
  • Valeur marchande globale : 10 670 $
  • Date approximative de vente : 07/07/2025
  • Intermédiaire : Charles Schwab & Co., Inc.
  • Bourse : NASDAQ
  • Total des actions en circulation : 228 486 470
  • Ventes récentes précédentes par le même vendeur : 2 729 actions le 07/04/2025 pour un produit brut de 18 379 $

La vente prévue représente environ 0,0004 % des actions en circulation de Sunrun, ce qui suggère un impact minimal sur la dilution ou le marché. Les actions ont été acquises via une levée de RSU (compensation en actions) le 07/07/2025. Le formulaire 144 confirme également que le déposant ne détient aucune information défavorable importante non divulguée concernant Sunrun.

Sunrun Inc. (RUN) hat ein Formular 144 eingereicht, das einen geplanten Verkauf von beschränkten Wertpapieren anzeigt.

  • Zu verkaufende Wertpapiere: 988 Stammaktien
  • Gesamtmarktwert: 10.670 $
  • Ungefähres Verkaufsdatum: 07.07.2025
  • Broker: Charles Schwab & Co., Inc.
  • Börse: NASDAQ
  • Gesamtzahl der ausstehenden Aktien: 228.486.470
  • Jüngste frühere Verkäufe desselben Verkäufers: 2.729 Aktien am 07.04.2025 mit Bruttoerlös von 18.379 $

Der geplante Verkauf entspricht etwa 0,0004 % der ausstehenden Sunrun-Aktien und deutet auf minimale Verwässerung oder Markteinfluss hin. Die Aktien wurden am 07.07.2025 durch das Ablaufen von RSUs (Aktienvergütung) erworben. Das Formular 144 bestätigt außerdem, dass der Einreicher keine nicht offengelegten wesentlichen nachteiligen Informationen über Sunrun besitzt.

false0001655050 0001655050 2025-06-30 2025-06-30
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM
8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 30, 2025
 
 
BAIN CAPITAL SPECIALTY FINANCE, INC.
(Exact name of Registrant as Specified in Its Charter)
 
 
 
Delaware
 
814-01175
 
81-2878769
(State or Other Jurisdiction
of Incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
200 Clarendon Street
 
37th Floor
 
Boston, Massachusetts
 
02116
(Address of Principal Executive Offices)
 
(Zip Code)
Registrant’s Telephone Number, Including Area Code: (617)
516-2000
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form
8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule
14a-12
under the Exchange Act (17 CFR
240.14a-12)
 
Pre-commencement
communications pursuant to Rule
14d-2(b)
under the Exchange Act (17 CFR
240.14d-2(b))
 
Pre-commencement
communications pursuant to Rule
13e-4(c)
under the Exchange Act (17 CFR
240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Common Stock, par value $0.001 per share   BCSF   New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule
12b-2
of the Securities Exchange Act of 1934
(§ 240.12b-2
of this chapter).
Emerging growth company 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 
 

Item 1.01.
Entry into a Material Definitive Agreement.
On July 2, 2025 (the “Reset Date”), BCC Middle Market CLO
2019-1,
Ltd. (the “CLO Issuer”) and BCC Middle Market CLO
2019-1
Co-Issuer,
LLC (the “CLO
Co-Issuer”
and together with the CLO Issuer, the “CLO Issuers”), both indirect, wholly-owned, consolidated subsidiaries of Bain Capital Specialty Finance, Inc. (the “Company”), closed the refinancing of a $430,250,000 term debt securitization in the form of a collateralized loan obligation (the “CLO Reset Transaction”).
The CLO Reset Transaction was executed through the issuance by the CLO Issuers of the following classes of notes pursuant that certain second amended and restated indenture (as amended, modified or supplemented from time to time, the “Amended and Restated Indenture”), dated as of the Reset Date, by and among the CLO Issuer, the
Co-Issuer,
and Wells Fargo Bank, National Association, as trustee (the “Trustee”): (i) $232,000,000 of AAA(sf)
Class A-1-RR
Senior Secured Floating Rate Notes due 2036, which bear interest at the three-month secured overnight financing rate published by the Federal Reserve Bank of New York (“SOFR”) plus 1.45% (the
“Class A-1-RR
Notes”); (ii) $16,000,000 of AAA(sf) of
Class A-2-RR
Senior Secured Floating Rate Notes due 2036, which bear interest at the three-month SOFR plus 1.60% (the
“Class A-2-RR
Notes”); (iii) $24,000,000 of AA(sf) of
Class A-3-RR
Senior Secured Floating Rate Notes due 2036, which bear interest at the three-month SOFR plus 1.85% (the
“Class A-3-RR
Notes”); (iv) $32,000,000 of A(sf)
Class 
B-RR
Secured Deferrable Floating Rate Notes due 2036, which bear interest at the three-month SOFR plus 2.35% (the
“Class B-RR
Notes”); and (vi) $24,000,000 of BBB(sf)
Class C-RR
Secured Deferrable Floating Rate Notes due 2036, which bear interest at the three-month SOFR plus 3.35% (the
“Class C-RR
Notes”, and, together with the
Class A-1-RR
Notes, the
Class A-2-RR
Notes and the
Class B-RR
Notes, the “Replacement Notes”).
The CLO Reset Transaction is backed by a diversified portfolio of middle-market commercial loans. The Replacement Notes will mature on July 15, 2036; however, the Replacement Notes may be redeemed by the CLO Issuers, at the direction of the CLO Issuer with the consent of the Company, in its capacity as portfolio manager and retention holder, on any business day after July 2, 2026. The Company continues to act as retention holder in connection with the CLO Reset Transaction for the purposes of satisfying certain U.S., U.K. and European Union regulations requiring sponsors of securitization transactions to retain exposure to the performance of the securitized assets and as such is required to continue to retain a portion of the preferred shares issued by the CLO Issuer (the “Interests”). The Replacement Notes were 100% funded at closing. The Company continues to retain 100% of the Interests.
The CLO Issuer intends to use the proceeds from the CLO Reset Transaction to, among other things, purchase certain loans (“Collateral Obligations”) from time to time on and after the Reset Date from the Company pursuant to a loan sale agreement entered into on August 28, 2019 (the “Loan Sale Agreement”) among the Company and the CLO Issuer. Under the terms of the Loan Sale Agreement that provide for the sale of Collateral Obligations to the CLO Issuer, the Company will transfer to the CLO Issuer, a portion of its ownership interest in the Collateral Obligations securing the Replacement Notes for the purchase price and other consideration set forth in the Loan Sale Agreement from time to time after the Reset Date. Following these transfers, the CLO Issuer, and not the Company, will hold all of the ownership interest in such loans and participations. The Company made customary representations, warranties and covenants in the Loan Sale Agreement.
The Replacement Notes are the secured obligation of the CLO Issuers, and the obligations of the CLO Issuers under the Replacement Notes are
non-recourse
to the Company. The Amended and Restated Indenture governing the Replacement Notes include customary covenants and events of default. The Replacement Notes have not been, and will not be, registered under the Securities Act of 1933, as amended, or any state securities or “blue sky” laws and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission or an applicable exemption from registration.
The Company continues to serve as portfolio manager to the CLO Issuer pursuant to a second amended and restated portfolio management agreement entered into on the Reset Date (the “Amended and Restated Portfolio Management Agreement”) and has agreed to irrevocably waive all portfolio management fees payable pursuant to the Amended and Restated Portfolio Management Agreement.

The above description of the documentation related to the CLO Reset Transaction and other arrangements entered into on the Reset Date contained in this Current Report on Form
8-K
do not purport to be complete and are qualified in their entirety by reference to the underlying agreements, including the Amended and Restated Indenture and the Amended and Restated Portfolio Management Agreement, attached hereto as Exhibits 10.1 and 10.2, respectively, and each incorporated into this Current Report on Form
8-K
by reference.
 
Item 2.03.
Creation of a Direct Financial Obligation or an Obligation under
an Off-Balance Sheet
Arrangement of a Registrant.
The information provided in Item 1.01 of this current report on Form
8-K
is incorporated by reference into this Item 2.03.
 
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits
 
Exhibit
No.
  
Description
10.1    Second Amended and Restated Indenture, dated as of July 2, 2025, by and among BCC Middle Market CLO 2019-1, Ltd., as issuer, BCC Middle Market CLO 2019-1 Co-Issuer, LLC, as co-issuer, and Wells Fargo Bank, National Association, as trustee.
10.2    Second Amended and Restated Portfolio Management Agreement, dated as of July 2, 2025, by and between BCC Middle Market CLO 2019-1, Ltd., as issuer, and Bain Capital Specialty Finance, Inc., as portfolio manager.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
   
BAIN CAPITAL SPECIALTY FINANCE, INC.
Date: July 7, 2025     By:  
/s/ Adriana Rojas Garzón
    Name:   Adriana Rojas Garzón
    Title:   Vice President

FAQ

How many Sunrun (RUN) shares are proposed to be sold under this Form 144?

A total of 988 common shares are listed for sale.

What is the aggregate market value of the shares to be sold?

The filing lists an aggregate market value of $10,670.

When is the approximate sale date for the shares?

The shares are expected to be sold on 07/07/2025.

On which exchange will the Sunrun shares be sold?

The shares are slated for sale on the NASDAQ.

How many shares has the same seller disposed of in the last three months?

The seller previously sold 2,729 shares on 04/07/2025 for gross proceeds of $18,379.

What is the total number of Sunrun shares outstanding?

The filing cites 228,486,470 shares outstanding.
Bain Capital Specialty Finance Inc

NYSE:BCSF

BCSF Rankings

BCSF Latest News

BCSF Latest SEC Filings

BCSF Stock Data

978.87M
62.48M
0.59%
55.44%
0.56%
Asset Management
Financial Services
Link
United States
BOSTON